Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Utilizing Synthetic Individual Patient Level Cohorts from Machine Learning on Clinical Trials to Define Endpoints for Bispecific Trials in Large B-Cell Lymphoma

Dai Chihara, Micheal J. Kane, Christopher R. Flowers, Brian P. Hobbs

Blood (2024) 144 (Supplement 1): 4462.

https://doi.org/10.1182/blood-2024-193578

Published: 2024

Journal Articles

Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes

Yasunobu Nagata, Ran Zhao, Hassan Awada, Cassandra M. Kerr, Inom Mirzaev, Sunisa Kongkiatkamon, Aziz Nazha, Hideki Makishima, Tomas Radivoyevitch, Jacob G. Scott, Mikkael A. Sekeres, Brian P. Hobbs, Jaroslaw P. Maciejewski

Blood (2020) 136 (20): 2249–2262.

https://doi.org/10.1182/blood.2020005488

Published: 2020

Includes: Supplemental data

Journal Articles

Are Racial Disparities in Acute Myeloid Leukemia (AML) Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction?

Abby Statler, PhD MPH, Brian P. Hobbs, PhD, Tomas Radivoyevitch, PhD, Sudipto Mukherjee, MD PhD MPH, Kimberly Bell, MBA, RN, BSN, Anjali S. Advani, MD, Aaron T. Gerds, MD MS, Aziz Nazha, MD, Bhumika J. Patel, MD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS

Blood (2019) 134 (Supplement_1): 381.

https://doi.org/10.1182/blood-2019-129096

Published: 2019

Journal Articles

Determinants of "Fitness" for Intensive Therapy Among Acute Myeloid Leukemia (AML) Patients

Abby Statler, PhDMPH, Brian P. Hobbs, PhD, Tomas Radivoyevitch, PhD, Caitlin Siebenaller, PharmD, Sudipto Mukherjee, MD PhD MPH, Anjali S. Advani, MD, Aaron T. Gerds, MD MS, Aziz Nazha, MD, Bhumika J. Patel, MD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS

Blood (2019) 134 (Supplement_1): 3836.

https://doi.org/10.1182/blood-2019-128853

Published: 2019

Journal Articles

A Single Arm, Phase II Study of Eltrombopag to Enhance Platelet Count Recovery in Older Patients with Acute Myeloid Leukemia (AML) Undergoing Remission Induction Therapy

Sudipto Mukherjee, MD PhD MPH, Hong Li, Brian P. Hobbs, PhD, Aaron T. Gerds, MD MS, Anjali S. Advani, MD, Hetty E. Carraway, MD MBA, Aziz Nazha, MD, Samjhana Bogati, RN, Eric Parsons, RN, Benjamin Pannell, Matt Kalaycio, MD, Yogenthiran Saunthararajah, MD, Jaroslaw P. Maciejewski, MD PhD, Mikkael A. Sekeres, MD MS

Blood (2019) 134 (Supplement_1): 2595.

https://doi.org/10.1182/blood-2019-132178

Published: 2019

Journal Articles

How Morphologic Features Are Shaped By Underlying Somatic Genotype in MDS

Yasunobu Nagata, MD PhD, Ran Zhao, Hassan Awada, Cassandra M Kerr, MS, Abhinav Goyal, Inom Mirzaev, Sunisa Kongkiatkamon, Aziz Nazha, MD, Tomas Radivoyevitch, PhD, Jacob Scott, MD, Mikkael A. Sekeres, MD MS, Brian P. Hobbs, PhD, Jaroslaw P. Maciejewski, MD PhD

Blood (2019) 134 (Supplement_1): 1716.

https://doi.org/10.1182/blood-2019-127285

Published: 2019

Journal Articles

The Impact of Comorbidities and Organ Dysfunction Commonly Used for Clinical Trial Eligibility Criteria on Outcome in Acute Myeloid Leukemia (AML) Patients Receiving Induction Chemotherapy

Blood (2019) 134 (Supplement_1): 16.

https://doi.org/10.1182/blood-2019-130319

Published: 2019

Journal Articles

Identifying Factors That Predict for Unplanned Readmissions for Acute Myeloid Leukemia Patients Receiving Consolidation Cytarabine Based Therapies

Caitlin Siebenaller, PharmD, Madeline Waldron, PharmD, BCOP, Kelly Gaffney, PharmD, Brian P. Hobbs, PhD, Ran Zhao, Marc Earl, PharmD, Marina Feldman, PharmD, BCCCP, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Aziz Nazha, MD, Aaron T. Gerds, MD MS, Bhumika J. Patel, MD, Betty K. Hamilton, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MD PhD MPH

Blood (2019) 134 (Supplement_1): 3433.

https://doi.org/10.1182/blood-2019-128807

Published: 2019

Journal Articles

Poisson Regression Modeling of Chronic Myeloid Leukemia Mortality Trends

Tomas Radivoyevitch, Brian P. Hobbs, PhD, Jaroslaw P. Maciejewski

Blood (2018) 132 (Supplement 1): 4274.

https://doi.org/10.1182/blood-2018-99-118143

Published: 2018

Journal Articles

Differences in Genomic Patterns between African Americans and Whites with Acute Myeloid Leukemia

Rachel Hu, MD, Aziz Nazha, Xuefei Jia, MS, Brian P. Hobbs, PhD, Hetty E. Carraway, MD MBA, Sudipto Mukherjee, MDPhDMPH, Aaron T. Gerds, MDMS, Anjali S. Advani, MD, Yasunobu Nagata, Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Babal K. Jha, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, MD MS

Blood (2018) 132 (Supplement 1): 1527.

https://doi.org/10.1182/blood-2018-99-114273

Published: 2018

Journal Articles

Pharmacist Interventions on Outpatient Leukemia Patients Improve Safety

Madeline Waldron, PharmD, Caitlin Siebenaller, PharmD, Marc Earl, PharmD, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Aziz Nazha, Aaron T. Gerds, MDMS, Betty K. Hamilton, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Barb Tripp, CNS, Brian P. Hobbs, PhD, Sudipto Mukherjee, MD PhD MPH, Mikkael A. Sekeres, MD MS

Blood (2018) 132 (Supplement 1): 712.

https://doi.org/10.1182/blood-2018-99-110029

Published: 2018

Journal Articles

Chronic Myeloid Leukemia Incidence Based Estimates of Hematopoietic Stem Cell Numbers per Person

Tomas Radivoyevitch, Brian P. Hobbs, PhD, Yasunobu Nagata, Jacob Scott, MD, Asha Kallianpour, MD, Takuya Sakaguchi, PhD, Jaroslaw P. Maciejewski, Yasushi Miyazaki, MD PhD

Blood (2018) 132 (Supplement 1): 5441.

https://doi.org/10.1182/blood-2018-99-119583

Published: 2018

Journal Articles

Venous Thromboembolism in Cancer Patients Receiving Immunotherapy

Joanna Roopkumar, MBBS, MPH, Ann S. Kim, BA, Thapa Bicky, MD, Brian P. Hobbs, PhD, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 2510.

https://doi.org/10.1182/blood-2018-99-116439

Published: 2018

Journal Articles

Evaluating the Evidence for Long-Term Benefit from Specialty Centers Versus Real World for MDS Patients Treated with HMA

Sudipto Mukherjee, MD PhD MPH, Tomas Radivoyevitch, PhD, Brian P. Hobbs, PhD, Xuefei Jia, MS, Rami S. Komrokji, MD, David P. Steensma, MD, Amy E. DeZern, MD, Gail J. Roboz, MD, Guillermo Garcia-Manero, MD, Jaroslaw P. Maciejewski, Aziz Nazha, Mikkael A. Sekeres, MD MS

Blood (2018) 132 (Supplement 1): 3095.

https://doi.org/10.1182/blood-2018-99-119146

Published: 2018

Journal Articles

Does Trial Participation Improve Outcomes for Higher-Risk Myelodysplastic Syndromes (MDS) Patients Treated at Specialty Centers?

Sudipto Mukherjee, MD PhD MPH, David P. Steensma, MD, Rami S. Komrokji, MD, Amy E. DeZern, MD, Gail J. Roboz, MD, Guillermo Garcia-Manero, MD, Aziz Nazha, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, MD MS, Brian P. Hobbs, PhD, Xuefei Jia, MS

Blood (2018) 132 (Supplement 1): 3096.

https://doi.org/10.1182/blood-2018-99-117174

Published: 2018

Journal Articles

Risk of Venous Thromboembolism in Acute Leukemias: A Meta-Analysis

Madeline Waldron, PharmD, Caitlin Siebenaller, PharmD, Brian P. Hobbs, PhD, Marc Earl, PharmD, Mary Schleicher, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Aziz Nazha, Aaron T. Gerds, MD MS, Betty K. Hamilton, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MD PhD MPH

Blood (2018) 132 (Supplement 1): 4805.

https://doi.org/10.1182/blood-2018-99-115256

Published: 2018

Journal Articles

Impact of Venous Thromboembolism during High Intensity Chemotherapy for Acute Leukemia Patients on Duration of Hospital Stay

Madeline Waldron, PharmD, Caitlin Siebenaller, PharmD, Marc Earl, PharmD, Xuefei Jia, MS, Hetty E. Carraway, MD MBA, Anjali S. Advani, MD, Aziz Nazha, Aaron T. Gerds, MD MS, Betty K. Hamilton, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Barb Tripp, CNS, Brian P. Hobbs, PhD, Mikkael A. Sekeres, MD MS, Sudipto Mukherjee, MD PhD MPH

Blood (2018) 132 (Supplement 1): 4806.

https://doi.org/10.1182/blood-2018-99-115257

Published: 2018

NARROW

Utilizing Synthetic Individual Patient Level Cohorts from Machine Learning on Clinical Trials to Define Endpoints for Bispecific Trials in Large B-Cell Lymphoma

Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes

Are Racial Disparities in Acute Myeloid Leukemia (AML) Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction?

Determinants of "Fitness" for Intensive Therapy Among Acute Myeloid Leukemia (AML) Patients

A Single Arm, Phase II Study of Eltrombopag to Enhance Platelet Count Recovery in Older Patients with Acute Myeloid Leukemia (AML) Undergoing Remission Induction Therapy

How Morphologic Features Are Shaped By Underlying Somatic Genotype in MDS

The Impact of Comorbidities and Organ Dysfunction Commonly Used for Clinical Trial Eligibility Criteria on Outcome in Acute Myeloid Leukemia (AML) Patients Receiving Induction Chemotherapy

Identifying Factors That Predict for Unplanned Readmissions for Acute Myeloid Leukemia Patients Receiving Consolidation Cytarabine Based Therapies

Poisson Regression Modeling of Chronic Myeloid Leukemia Mortality Trends

Differences in Genomic Patterns between African Americans and Whites with Acute Myeloid Leukemia

Pharmacist Interventions on Outpatient Leukemia Patients Improve Safety

Chronic Myeloid Leukemia Incidence Based Estimates of Hematopoietic Stem Cell Numbers per Person

Venous Thromboembolism in Cancer Patients Receiving Immunotherapy

Evaluating the Evidence for Long-Term Benefit from Specialty Centers Versus Real World for MDS Patients Treated with HMA

Does Trial Participation Improve Outcomes for Higher-Risk Myelodysplastic Syndromes (MDS) Patients Treated at Specialty Centers?

Risk of Venous Thromboembolism in Acute Leukemias: A Meta-Analysis

Impact of Venous Thromboembolism during High Intensity Chemotherapy for Acute Leukemia Patients on Duration of Hospital Stay

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only